Figure 7.
IFN‐γ and IL‐4 levels in splenocytes from Hepa1‐6 tumor‐bearing mice. C57BL/6 mice harboring established subcutaneous Hepa1‐6 tumors in the left flank were treated with mock preparation or T‐01 (2 × 106 pfu) twice (days 0 and 3). IFN‐γ and IL‐4 ELISPOT assays were performed in splenocytes from treated groups. Data represent the mean ± SE (n = 3 mice per group). **P < .01 vs mock treatment